Exact Sciences (EXAS) Capital Expenditures (2016 - 2025)
Exact Sciences has reported Capital Expenditures over the past 16 years, most recently at $31.2 million for Q4 2025.
- Quarterly Capital Expenditures rose 157.15% to $31.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $134.7 million through Dec 2025, up 199.24% year-over-year, with the annual reading at $134.7 million for FY2025, 199.24% up from the prior year.
- Capital Expenditures was $31.2 million for Q4 2025 at Exact Sciences, up from $29.9 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $72.9 million in Q4 2022 and troughed at -$88.8 million in Q4 2023.
- The 5-year median for Capital Expenditures is $31.2 million (2025), against an average of $22.6 million.
- Year-over-year, Capital Expenditures surged 498.21% in 2022 and then crashed 221.81% in 2023.
- A 5-year view of Capital Expenditures shows it stood at -$18.3 million in 2021, then surged by 498.21% to $72.9 million in 2022, then crashed by 221.81% to -$88.8 million in 2023, then surged by 38.41% to -$54.7 million in 2024, then surged by 157.15% to $31.2 million in 2025.
- Per Business Quant, the three most recent readings for EXAS's Capital Expenditures are $31.2 million (Q4 2025), $29.9 million (Q3 2025), and $42.3 million (Q2 2025).